Cargando…

The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant

5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a potent type I interferon (IFN) inducer, was evaluated as a chemotherapeutic agent in mouse cancer models and proved to be well tolerated in human cancer clinical trials. Despite its multiple biological functions, DMXAA has not been fully characterized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Choon Kit, Aoshi, Taiki, Jounai, Nao, Ito, Junichi, Ohata, Keiichi, Kobiyama, Kouji, Dessailly, Benoit H., Kuroda, Etsushi, Akira, Shizuo, Mizuguchi, Kenji, Coban, Cevayir, Ishii, Ken J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605442/ https://www.ncbi.nlm.nih.gov/pubmed/23555875 http://dx.doi.org/10.1371/journal.pone.0060038

Ejemplares similares

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
por: Temizoz, Burcu, et al.
Publicado: (2015)

Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination
por: Kobiyama, Kouji, et al.
Publicado: (2013)

DNA vaccines: A simple DNA sensing matter?
por: Coban, Cevayir, et al.
Publicado: (2013)

RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine
por: Hayashi, Masayuki, et al.
Publicado: (2016)

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
por: Roberts, Zachary J., et al.
Publicado: (2007)

Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use
por: Aoshi, Taiki, et al.
Publicado: (2015)

ZBP1 governs the inflammasome-independent IL-1α and neutrophil inflammation that play a dual role in anti-influenza virus immunity
por: Momota, Masatoshi, et al.
Publicado: (2019)

Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells
por: Kitahata, Yuji, et al.
Publicado: (2016)

Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor
por: Ozasa, Koji, et al.
Publicado: (2019)

Particulate Adjuvant and Innate Immunity: Past Achievements, Present Findings, and Future Prospects
por: Kuroda, Etsushi, et al.
Publicado: (2013)

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination
por: Jounai, Nao, et al.
Publicado: (2013)

Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants
por: Hioki, Kou, et al.
Publicado: (2022)

Role of Extrachromosomal Histone H2B on Recognition of DNA Viruses and Cell Damage
por: Kobiyama, Kouji, et al.
Publicado: (2013)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination
por: Hemmi, Masahisa, et al.
Publicado: (2017)

Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome
por: Takemura, Naoki, et al.
Publicado: (2014)

Ligand-induced Ordering of the C-terminal Tail Primes STING for Phosphorylation by TBK1
por: Tsuchiya, Yuko, et al.
Publicado: (2016)

RNA Polymerase III Regulates Cytosolic RNA:DNA Hybrids and Intracellular MicroRNA Expression
por: Koo, Christine Xing'er, et al.
Publicado: (2015)

The Early Activation of CD8(+) T Cells Is Dependent on Type I IFN Signaling following Intramuscular Vaccination of Adenovirus Vector
por: Hemmi, Masahisa, et al.
Publicado: (2014)

Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides
por: Takahashi, Hideki, et al.
Publicado: (2018)

DAMP-Inducing Adjuvant and PAMP Adjuvants Parallelly Enhance Protective Type-2 and Type-1 Immune Responses to Influenza Split Vaccination
por: Hayashi, Tomoya, et al.
Publicado: (2018)

The host targeting effect of chloroquine in malaria
por: Coban, Cevayir
Publicado: (2020)

Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
por: Chang, Jiajia, et al.
Publicado: (2023)

B cell–intrinsic TBK1 is essential for germinal center formation during infection and vaccination in mice
por: Lee, Michelle S.J., et al.
Publicado: (2021)

Tissue-specific immunopathology during malaria infection
por: Coban, Cevayir, et al.
Publicado: (2018)

Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression
por: Rauca, Valentin-Florian, et al.
Publicado: (2021)

Dissection of stromal and cancer cell-derived signals in melanoma xenografts before and after treatment with DMXAA
por: Henare, K, et al.
Publicado: (2012)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Essential role of IPS-1 in innate immune responses against RNA viruses
por: Kumar, Himanshu, et al.
Publicado: (2006)

Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA
por: Gao, Pu, et al.
Publicado: (2014)

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
por: Weiss, Julia M., et al.
Publicado: (2017)

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021)

Modes of Action for Mucosal Vaccine Adjuvants
por: Aoshi, Taiki
Publicado: (2017)

Quantifying the relative immune cell activation from whole tissue/organ-derived differentially expressed gene data
por: Wijaya, Edward, et al.
Publicado: (2017)

Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin
por: Coban, Cevayir, et al.
Publicado: (2005)

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
por: Uematsu, Satoshi, et al.
Publicado: (2005)

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice
por: Zhao, L, et al.
Publicado: (2002)

Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)
por: Tijono, S M, et al.
Publicado: (2013)

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2018)

Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins
por: Tsuchida, Tetsuo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_p9jq6t20nu7077u7odtd8l0fil